Antigenics to Webcast 2006 Annual Shareholders Meeting.NEW YORK -- Antigenics Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on : AGEN) invites investors and the general public to listen to a live audio webcast of its 2006 Annual Shareholders Meeting at 5:00 p.m. ET on Wednesday, June 14. The meeting will be held at The Graduate Center of The City University of New York The City University of New York (CUNY; acronym: IPA pronunciation: [kjuni]), is the public university system of New York City. , 365 Fifth Avenue in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . The meeting agenda will include: --Comments from Andrew T. Parsa, MD, PhD, assistant professor in the department of neurological surgery at the University of California, San Francisco , and principal investigator of the Phase 1/2 clinical trial testing Oncophage(R) (vitespen) in recurrent glioma glioma /gli·o·ma/ (gli-o´mah) a tumor composed of neuroglia in any of its states of development; sometimes extended to include all intrinsic neoplasms of the brain and spinal cord, as astrocytomas, ependymomas, etc. . Dr. Parsa will discuss the use of Oncophage in the treatment of cancer, particularly in light of recent Phase 3 clinical data. --Members of Antigenics' management team will discuss development planning for Aroplatin(TM), a platinum chemotherapeutic designed to reduce certain types of toxicities typically associated with other platinum agents and to overcome drug resistance. --Management will also discuss recent developments related to the QS-21 adjuvant program, which is incorporated in a number of vaccines that are in advanced stages of clinical development by Antigenics' corporate partners. --The meeting will close with a general corporate update from Garo Armen, PhD, chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of Antigenics, followed by a question and answer period, then the formal meeting proceedings. The live webcast will be accessible from the company's website at www.antigenics.com/webcast/ and will be archived and available for replay approximately two hours after the meeting. Antigenics is a biotechnology company developing treatments for cancers, infectious diseases and autoimmune disorders. For more information, please visit www.antigenics.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion